Skip to main content
Metaflammation SFB

News categories: Honors & Funding

Collaborative Research Center "Metaflammation" extended

With the participation of scientists from ImmunoSensation, the Collaborative Research Centre "Metaflammation and Cellular Programming" is investigating the links between lifestyle and inflammatory processes. The German Research Foundation has now extended funding for the research centre.

The CRC 1454 ‘Metaflammation and Cellular Programming’ is already entering its second funding period. It deals with the connection between a Western lifestyle and chronic inflammatory diseases - for example, how an excessive calorie intake coupled with insufficient exercise favours the development of cardiovascular diseases, neurodegenerative diseases or metabolic syndrome.

Using a holistic approach, the researchers are investigating why lifestyle or environmental factors, such as obesity, smoking or insufficient exercise, influence the misprogramming of immune cells and thus cause ‘metaflammation’ - a chronic inflammation triggered by the immune system. The researchers are investigating how the interaction of cells in inflamed tissue takes place and how molecular signalling pathways contribute to the development of diseases during metaflammation.

The scientific network is part of the Transdisciplinary Research Area (TRA) ‘Life and Health’ and combines the expertise of scientists from the Faculty of Medicine, the Faculty of Mathematics and Natural Sciences and the Faculty of Agricultural, Nutritional and Engineering Sciences as well as the Cluster of Excellence ImmunoSensation2 and the University Hospital Bonn (UKB). Researchers from the German Centre for Neurodegenerative Diseases (DZNE) in Bonn, the Max Planck Institute for Metabolic Research in Cologne, the German Rheumatism Research Centre in Berlin and the Technical University of Braunschweig are also involved.

Please visit the CRC Metaflammation website for further information.

 

Contact

Prof. Dagmar Wachten

Institute of Innate Immunity

University Hospital Bonn

E-Mail: dwachten@uni-bonn.de

 

Related news

Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Prof. Dr. Jörg Wenzel

News categories: Honors & Funding

Jörg Wenzel elected chair of EADV Task Force on Cutaneous Lupus Erythematosus (CLE)

The European Academy of Dermatology and Venereology (EADV) has establishment a new Task Force on Cutaneous Lupus Erythematosus (CLE), led by ImmunoSensation³ member Jörg Wenzel. CLE, as autoimmune disease of the skin, is a prime example of chronic inflammatory dysregulation, leading to a severe disease burden. The treatment of cutaneous lupus continues to face unresolved clinical challenges. The CLE Task Force is set up to push the boundaries of clinical care, update guidelines, and advance collaborative research across Europe.
EADV Task Forces

Back to the news overview